{"protocolSection":{"identificationModule":{"nctId":"NCT05176600","orgStudyIdInfo":{"id":"FDG_Birehab_2021"},"organization":{"fullName":"Wearable Robotics srl.","class":"INDUSTRY"},"briefTitle":"Bimanual Robotic Exoskeletal Platform for the Treatment of the Upper Limb in Patients With Stroke. A Feasibility Study","officialTitle":"Pilot Study on the Evaluation of the Functionality, Safety and Feasibility of a Bimanual Robotic Exoskeletal Platform for the Treatment of the Upper Limb in Patients With Stroke","acronym":"Birehab"},"statusModule":{"statusVerifiedDate":"2022-04","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2022-01-10","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2022-09","type":"ESTIMATED"},"completionDateStruct":{"date":"2022-09","type":"ESTIMATED"},"studyFirstSubmitDate":"2021-11-10","studyFirstSubmitQcDate":"2022-01-03","studyFirstPostDateStruct":{"date":"2022-01-04","type":"ACTUAL"},"lastUpdateSubmitDate":"2022-04-22","lastUpdatePostDateStruct":{"date":"2022-04-29","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Lucia Lencioni","investigatorTitle":"CEO","investigatorAffiliation":"Wearable Robotics srl."},"leadSponsor":{"name":"Wearable Robotics srl.","class":"INDUSTRY"},"collaborators":[{"name":"Fondazione Don Carlo Gnocchi Onlus","class":"OTHER"}]},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The purpose of the study is to test the technical functionality, safety, and feasibility of a bimanual robotic exoskeletal platform and associated serious games in order to offer information on technological and functional advances that will be included in the device's finalization.\n\nIn addition, a secondary goal will be to assess the therapeutic effects of a rehabilitation therapy based on the bimanual configuration, comparing it to a unimanual treatment delivered on the same platform (using the specific configuration)."},"conditionsModule":{"conditions":["Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"SINGLE","whoMasked":["OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":20,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Bimanual group","type":"EXPERIMENTAL","description":"In this group, patients will perform a robotic rehabilitation based on bimanual serious games","interventionNames":["Device: Robotic rehabilitation using the Arm Light Exoskeleton Rehab Station (ALEx RS) and bimanual serious games"]},{"label":"Unimanual group","type":"ACTIVE_COMPARATOR","description":"In this group, patients will perform a robotic rehabilitation based on unimanual serious games","interventionNames":["Device: Robotic rehabilitation using the Arm Light Exoskeleton Rehab Station (ALEx RS) and unimanual serious games"]}],"interventions":[{"type":"DEVICE","name":"Robotic rehabilitation using the Arm Light Exoskeleton Rehab Station (ALEx RS) and bimanual serious games","description":"Patients will undergo a bimanual 30-session robotic rehabilitation, using the robot ALEx RS with the bimanual configuration and the related serious games. Each session will last 45 minute. Daily sessions will be provided, five days a week.","armGroupLabels":["Bimanual group"]},{"type":"DEVICE","name":"Robotic rehabilitation using the Arm Light Exoskeleton Rehab Station (ALEx RS) and unimanual serious games","description":"Patients will undergo a unimanual 30-session robotic rehabilitation, using the robot ALEx RS with the unimanual configuration and the related serious games.Daily sessions will be provided, five days a week.","armGroupLabels":["Unimanual group"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Incidence of adverse events and description","description":"Number and description of adverse events related to the provided intervention","timeFrame":"through the study, an average of 10 months"}],"secondaryOutcomes":[{"measure":"Changes in EEG-based Interhemispheric coupling index","description":"Interhemispheric coupling evaluated by means of 64-channel Electroencephalogram (EEG)","timeFrame":"Before the intervention, after a 1-hour robotic rehabilitation session"},{"measure":"Changes in EEG-based Interhemispheric coupling index","description":"Interhemispheric coupling evaluated by means of 64-channel Electroencephalogram (EEG)","timeFrame":"Before the intervention, after a 6-week robotic rehabilitation intervention"},{"measure":"Changes in EEG-based Interhemispheric coupling index","description":"Interhemispheric coupling evaluated by means of 64-channel Electroencephalogram (EEG)","timeFrame":"Before the intervention, 1 week after the end of the 30-session robotic intervention"},{"measure":"Changes in EEG-based Connectivity index","description":"Connectivity evaluated by means of 64-channel Electroencephalogram (EEG)","timeFrame":"Before the intervention, after a 1-hour robotic rehabilitation session"},{"measure":"Changes in EEG-based Connectivity index","description":"Connectivity evaluated by means of 64-channel Electroencephalogram (EEG)","timeFrame":"Before the intervention, after a 6-week robotic rehabilitation intervention"},{"measure":"Changes in EEG-based Connectivity index","description":"Connectivity evaluated by means of 64-channel Electroencephalogram (EEG)","timeFrame":"Before the intervention, 1 week after the end of the 30-session robotic intervention"},{"measure":"Changes in Fugl-meyer Assessment Upper Extremity motor functioning","description":"It is a stroke-specific, performance-based impairment index. It ranges from 0 (hemiplegia) to 66 points (normal).","timeFrame":"Before the intervention, after a 6-week robotic rehabilitation intervention"},{"measure":"Changes in Fugl-meyer Assessment - Sensory functioning","description":"It is a stroke-specific, sensory impairment index. It ranges from 0 (worse) to 12points (best).","timeFrame":"Before the intervention, after a 6-week robotic rehabilitation intervention"},{"measure":"Changes in Modified Ashworth Scale","description":"It is a validated measure of spasticity. It ranges from 0 (normal) to 4 (rigid limb).","timeFrame":"Before the intervention, after a 6-week robotic rehabilitation intervention"},{"measure":"Changes in Motricity Index for upper extremity","description":"It is a validated measure of upper limb strength. It ranges from 0 (worse) to 100 (normal strength).","timeFrame":"Before the intervention, after a 6-week robotic rehabilitation intervention"},{"measure":"Changes in Wolf Motor Function Test","description":"It is a validated measure of upper extremity motor ability through timed and functional tasks.\n\nThe scores ranges from 0 to 75; lower scores are indicative of lower functioning levels.","timeFrame":"Before the intervention, after a 6-week robotic rehabilitation intervention"},{"measure":"Changes in Action Research Arm Test (ARAT)","description":"It is a valid measure of upper-extremity functional limitation. The total score on the ARAT ranges from 0 to 57, with the lowest score indicating that no movements can be performed, and the upper score indicating normal performance.","timeFrame":"Before the intervention, after a 6-week robotic rehabilitation intervention"},{"measure":"Changes in Execution time (seconds) measured with the robot","description":"It is the time (in seconds) required to perform reaching movement using the robot","timeFrame":"Before the intervention, after a 6-week robotic rehabilitation intervention"},{"measure":"Changes in Range of Motion (degrees) measured with the robot","description":"It is the range of motion (measured in degrees) of shoulder and elbow evaluated using the robot","timeFrame":"Before the intervention, after a 6-week robotic rehabilitation intervention"},{"measure":"Changes in Number of velocity peaks measured with the robot","description":"It is a measure of movement smoothness while performing reaching movements with the robot.","timeFrame":"Before the intervention, after a 6-week robotic rehabilitation intervention"},{"measure":"System Usability Scale","description":"It is a self-administered questionnaire to evaluate usability. It ranges from 0 to 100. Higher scores mean better usability.","timeFrame":"After a 6-week robotic rehabilitation intervention"},{"measure":"Technology Acceptance Model (TAM)","description":"It is a self-administered questionnaire to evaluate the acceptance of the provided.\n\nIt comprises several questions rated on a 7-point likert scale.","timeFrame":"After a 6-week robotic rehabilitation intervention"},{"measure":"Likert for Satisfaction","description":"Satisfaction will be assessed using a 11-point likert scale. It ranges from 0 to 10. Higher scores mean higher satisfaction.","timeFrame":"After a 6-week robotic rehabilitation intervention"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* height between 150 and 190 cm;\n* weight not exceeding 130 kg;\n* ischemic injury;\n* first cortical and supra-tentorial event;\n* moderate motor deficit of the upper limb (score on the Fugl-Meyer Assessment - Upper Extremity between 29 and 42);\n* time since stroke event between 1 and 6 months;\n* trunk control test score greater than or equal to 48;\n* healthy bone density and skeleton that does not suffer from unhealed fractures.\n\nExclusion Criteria:\n\n* Relevant medical comorbidities (severe neurological diseases, cardiovascular diseases, diabetes / unstabilized hypertension);\n* Cognitive impairment that prevents understanding of the exercises administered;\n* Unavailability to provide informed consent;\n* Pregnant women;\n* Severe spasticity (Ashworth 4);\n* Major muscle contractures;\n* Excessive asymmetry in the length of the arms;\n* Upper limb prostheses;\n* Excessive joint limitations that make it difficult or painful to use the device;\n* Use of pacemakers or implantation of active devices;\n* Patients who already participate in another clinical study or who are already undergoing another similar robotic rehabilitation treatment.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Irene Aprile, MD, PhD","role":"CONTACT","phone":"+390633086553","email":"iaprile@dongnocchi.it"}],"overallOfficials":[{"name":"Irene Aprile, MD, PhD","affiliation":"Fondazione Don Carlo Gnocchi Onlus","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Fondazione Don Carlo Gnocchi","status":"RECRUITING","city":"Rome","zip":"00168","country":"Italy","contacts":[{"name":"Irene Aprile, MD, PhD","role":"CONTACT","phone":"+390688036553","email":"iaprile@dongnocchi.it"}],"geoPoint":{"lat":41.89193,"lon":12.51133}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"}]}},"hasResults":false}